Search

Author/Creator Stach, Christian

2. Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis. Issue 1 (24th April 2017)

Authors:
Braun, Jürgen; Baraliakos, Xenofon; Hermann, Kay-Geert; Landewé, Robert; Machado, Pedro M; Maksymowych, Walter P; Davies, Owen; Hoepken, Bengt; Nurminen, Tommi; Stach, Christian; van der Heijde, Désirée
Journal:
RMD open
Issue:
Volume 3:Issue 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials. Issue 2 (28th January 2017)

Authors:
Clowse, Megan E. B.; Wallace, Daniel J.; Furie, Richard A.; Petri, Michelle A.; Pike, Marilyn C.; Leszczyński, Piotr; Neuwelt, C. Michael; Hobbs, Kathryn; Keiserman, Mauro; Duca, Liliana; Kalunian, Kenneth C.; Galateanu, Catrinel; Bongardt, Sabine; Stach, Christian; Beaudot, Carolyn; Kilgallen, B...
Other Names:
Batalov A. investigator.; Bojinca M. investigator.; Djerassi R. investigator.; Duca L. investigator.; Horak P. investigator.; Kolarov Z. investigator.; Milasiene R. investigator.; Monova D. investigator.; Otsa K. investigator.; Pileckyte M. investigator.; Popova T. investigator.; Radulescu F. inv...
Journal:
Arthritis & rheumatology
Issue:
Volume 69:Issue 2(2017)
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials. Issue 2 (February 2017)

Authors:
Clowse, Megan E. B.; Wallace, Daniel J.; Furie, Richard A.; Petri, Michelle A.; Pike, Marilyn C.; Leszczyński, Piotr; Neuwelt, C. Michael; Hobbs, Kathryn; Keiserman, Mauro; Duca, Liliana; Kalunian, Kenneth C.; Galateanu, Catrinel; Bongardt, Sabine; Stach, Christian; Beaudot, Carolyn; Kilgallen, B...
Other Names:
Batalov A. investigator.; Bojinca M. investigator.; Djerassi R. investigator.; Duca L. investigator.; Horak P. investigator.; Kolarov Z. investigator.; Milasiene R. investigator.; Monova D. investigator.; Otsa K. investigator.; Pileckyte M. investigator.; Popova T. investigator.; Radulescu F. inv...
Journal:
Arthritis & rheumatology
Issue:
Volume 69:Issue 2(2017)
Page Start:
362
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. FRI0195 EFFICACY AND SAFETY OF DAPIROLIZUMAB PEGOL (DZP) IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A RANDOMISED, PLACEBO (PBO)-CONTROLLED STUDY. (June 2019)

Authors:
Furie, Richard; Bruce, Ian N.; Dörner, Thomas; Leon, Manuel Gustavo; Leszczynski, Piotr; Urowitz, Murray B.; Haier, Birgit; Jimenez, Teri; Barbey, Catherine; Liu, Jiajun; Stach, Christian
Journal:
Annals of the rheumatic diseases
Issue:
Volume 78(2019)Supplement 2
Page Start:
775
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus. (6th May 2021)

Authors:
Furie, Richard A; Bruce, Ian N; Dörner, Thomas; Leon, Manuel Gustavo; Leszczyński, Piotr; Urowitz, Murray; Haier, Birgit; Jimenez, Teri; Brittain, Claire; Liu, Jiajun; Barbey, Catherine; Stach, Christian
Journal:
Rheumatology
Issue:
Volume 60:Number 11(2021)
Page Start:
5397
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion. Issue 9 (27th May 2011)

Authors:
Finzel, Stephanie; Rech, Juergen; Schmidt, Sarah; Engelke, Klaus; Englbrecht, Matthias; Stach, Christian; Schett, Georg
Journal:
Annals of the rheumatic diseases
Issue:
Volume 70:Issue 9(2011)
Page Start:
1587
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. Issue 11 (5th August 2017)

Authors:
Chamberlain, Chris; Colman, Peter J; Ranger, Ann M; Burkly, Linda C; Johnston, Geoffrey I; Otoul, Christian; Stach, Christian; Zamacona, Miren; Dörner, Thomas; Urowitz, Murray; Hiepe, Falk
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76:Issue 11(2017)
Page Start:
1837
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus. (13th December 2021)

Authors:
Morel, Thomas; Cano, Stefan; Bartlett, Susan J; Gordon, Caroline; Haier, Birgit; Regnault, Antoine; Schneider, Matthias; Stach, Christian; Cleanthous, Sophie
Journal:
Rheumatology
Issue:
Volume 61:Number 8(2022)
Page Start:
3329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗